Eli Lilly
Venture Capital
Global pharmaceutical company with a corporate venture arm (Lilly Ventures) investing in early-stage biotech, health tech, and life sciences companies.
Pre-Seed
Seed
Early Stage
Growth
Biotech
Digital Health
Healthcare
biotechnology
life sciences
pharmaceuticals
- Headquarters
- Indianapolis, United States
- Founded
- 2002
- Website
- lilly.com
- AUM
- $300.0M
- Total Investments
- 21
- Last Investment
- Jan 2026
- Geographic Focus
- Global, United States, global
Investment Thesis
Invest in early-stage biotechs and health tech companies agnostic of therapeutic area, enabling novel modality platforms and advancing new medicines through Lilly Ventures.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account